About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The company is targeting treatment of both niche and prevalent indications, including diabetes, dyslipidemia and cardiovascular disease.

Top 100 in Pharmaceutical
Top 100 in Medical Device
Top 100 in Biopharma
Top 100 in Medical in United States
Top 100 in Pharmaceutical in United States
Top 100 in Biotechnology in United States
Top 100 in Medical Device in United States
Top 100 in Biopharma in United States
Company Highlights
Year Founded

2016

icon-altStatus

Acquired

icon-altEmployees

486

Location (HQ)

USA

Since Last Funding

5 months

Monthly Website Visitors

17.1K

icon-altTotal Investment Amt

$1.6B

Last Funding Round

Post Ipo Equity

icon-altMoM Headcount Growth

2.97%

icon-altYoY Headcount Growth

185.77%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Medical Device

Biotechnology

Pharmaceutical

Pharmaceutical Manufacturing